InsidersTradesSigma
Follow the IRLAB Therapeutics AB share price and the full insider trade history of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, IRLAB Therapeutics AB has recorded 24 public disclosures. Market capitalisation: €113m. The latest transaction was disclosed on 9 July 2026 (Purchase). Among the most active insiders: Joakim Tedroff. Every trade is free.
24
Insider Decl.
n/a
Thresholds
€1m
24 ops.
Buy Volume
n/a
n/a
Sell Volume
38Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 July 2026
Declarations24 total
10,500 shares@ €0.140.014% mcap2.3% of flowAktieISIN SE0012675361FI:csv-7a3c2db5bd0c5cc0c6bf
200,000 shares@ €0.150.28% mcap47.7% of flowAktieISIN SE0012675361FI:csv-4d1c5ffaada541c4ab44
10,500 shares@ €0.140.014% mcap4.7% of flowAktieISIN SE0012675361FI:csv-35717e7a0931ae76cb93
200,000 shares@ €0.150.28% mcap100.0% of flowAktieISIN SE0012675361FI:csv-844ff39e4cac1d0d42e2
97,369 shares@ SEK 1.200.10% mcap32.5% of flowAktieISIN SE0012675361FI:csv-75e3ad9e602aca825661
202,631 shares@ SEK 1.200.22% mcap67.5% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-22bfd22bba1034efbae4
140,716 shares@ SEK 1.200.15% mcap67.5% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-2c830c6519ddb45ef9a1
67,618 shares@ SEK 1.200.071% mcap32.5% of flowAktieISIN SE0012675361FI:csv-6afbe8f6601ec1188497
112,573 shares@ SEK 1.200.12% mcap67.5% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-a2fc0dc8407569dc4fe0
54,094 shares@ SEK 1.200.057% mcap32.5% of flowAktieISIN SE0012675361FI:csv-38d280ab09db282c0366
52,333 shares@ SEK 1.200.0052% mcap62.8% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-c6e5dad78154c1e4dd97
31,000 shares@ SEK 1.200.0031% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-d7e8a96b42391e08e898
183,858 shares@ SEK 1.200.018% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-df7cf2154fe892975198
4,016,742 shares@ SEK 1.200.41% mcap88.1% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-fd654d5a64a63337a524
250,000 shares@ SEK 1.200.026% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-644fe006c9298328bad7
66,142 shares@ SEK 1.200.0068% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-7f4c847a7582f9e90c96
427,416 shares@ SEK 1.200.044% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-bc0ef732bc436e9724fa
555,842 shares@ SEK 1.200.55% mcap22.5% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-442236d17577c19fb895
555,842 shares@ SEK 1.200.057% mcap22.5% of flowBTA (betald tecknad aktie)ISIN SE0025400179FI:csv-042e9dab302a546e5d34
250,000 shares@ €0.18190.042% mcap78.2% of flowAktieISIN SE0012675361FI:A003U250-1
70,000 shares@ €0.18160.012% mcap21.8% of flowAktieISIN SE0012675361FI:A003U002-1
36,000 shares@ €0.31230.010% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0025400179FI:A003R127-1
357,327 shares@ €0.30960.10% mcap75.5% of flowBTA (betald tecknad aktie)ISIN SE0025400179FI:A003Q791-1
116,196 shares@ €0.30960.033% mcap24.5% of flowBTA (betald tecknad aktie)ISIN SE0025400179FI:A003Q787-1
24 of 24 declarations
About IRLAB Therapeutics AB
IRLAB Therapeutics AB is a Swedish biopharmaceutical company focused on developing treatments for neurodegenerative diseases. It is listed on the Stockholm Stock Exchange (XSTO).